VR Logo

Unrated

Axis NIFTY Healthcare ETF download report


1 Lakh

Investment declined to
₹ 0.91 Lakh

₹ 10000

Monthly SIP Declined to
₹ 1.17 Lakh

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 5,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Axis NIFTY Healthcare ETF-G -8.64 0.17 -0.19 3.27 4.22 -1.50 -8.95 -- -- -- --
S&P BSE Healthcare TRI -10.66 0.20 0.35 3.25 3.13 -2.80 -10.64 -- -- -- --
Equity: Sectoral-Pharma -9.58 0.03 0.11 2.59 3.58 -1.80 -8.94 -- -- -- --
Rank within category 7 5 13 4 6 8 8 -- -- -- --
Number of funds in category 15 16 16 15 15 15 13 9 4 3 3

As on 17-Aug-2022

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
Axis NIFTY Healthcare ETF
Unrated
May-21 -8.95 -- -- 0.22 21
Nippon India Pharma Fund
Unrated
Jun-04 -9.56 26.64 17.90 1.98 4,620
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund  | Invest Now
Unrated
Jul-18 -8.44 26.65 -- 2.07 2,503
Mirae Asset Healthcare Fund - Regular Plan  | Invest Online
Unrated
Jul-18 -7.29 29.93 -- 2.10 1,738
SBI Healthcare Opportunities Fund  | Invest Online
Unrated
Jul-99 -6.92 25.70 12.25 2.18 1,668

Best & Worst Performance

Best Performance Worst Performance
Return (%) Period Return (%) Period
Week 6.77 07-Mar-2022 - 14-Mar-2022 -7.05 02-May-2022 - 10-May-2022
Month 9.12 07-Mar-2022 - 06-Apr-2022 -10.87 12-Apr-2022 - 12-May-2022
Quarter 8.98 04-Jun-2021 - 03-Sep-2021 -14.01 17-Mar-2022 - 17-Jun-2022
Year -5.43 21-May-2021 - 23-May-2022 -14.72 02-Jul-2021 - 04-Jul-2022

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Axis NIFTY Healthcare ETF-G -- -- -- -- -- --
S&P BSE Healthcare TRI* 22.78 22.44 0.86 1.63 -- --
Equity: Sectoral-Pharma* 23.87 20.45 1.00 1.96 0.89 3.20
Rank within category -- -- -- -- -- --
Number of funds in category -- -- -- -- -- --

The Risk Measures have been calculated using calendar month returns for the last three years.

As on

* As on 31-Jul-2022

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 20
Top 10 Stocks (%) 82.03
Top 5 Stocks (%) 64.19
Top 3 Sectors (%) 99.76
Portfolio P/B Ratio 4.40
Portfolio P/E Ratio 36.12

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 68,417 56,506
Giant (%) 22.11 20.17
Large (%) 45.51 35.87
Mid (%) 30.57 36.51
Small (%) 1.80 7.35
Tiny (%) -- 0.54

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
up Sun Pharmaceutical Industries Healthcare 56.51 22.06 14.35 22.06
up Cipla Healthcare 33.50 11.50 9.05 11.48
up Dr. Reddy's Lab Healthcare 23.51 13.17 10.45 10.73
up Divi's Laboratories Healthcare 32.01 13.67 10.27 10.58
up Apollo Hospitals Healthcare 69.51 11.67 6.58 9.34
up Laurus Labs Healthcare 37.88 5.19 4.05 4.45
up Alkem Laboratories Healthcare 26.84 3.69 2.56 3.43
up Lupin Healthcare -- 6.01 3.34 3.37
up Aurobindo Pharma Healthcare 14.24 5.80 3.32 3.32
up Torrent Pharmaceuticals Healthcare 66.12 3.27 2.73 3.27
up Biocon Healthcare 53.30 3.72 3.04 3.04
up Ipca Laboratories Healthcare 32.57 3.33 2.74 2.97
up Abbott India Healthcare 49.96 2.31 0.00 2.31
up Zydus Lifesciences Healthcare 9.03 3.25 1.85 1.93
up Dr. Lal Pathlabs Healthcare 77.69 2.51 1.52 1.62
up Syngene International Healthcare 60.80 1.50 0.00 1.43
up Pfizer Healthcare 43.32 1.77 1.40 1.42
up Glenmark Pharma. Healthcare 13.62 1.92 1.21 1.21
up Granules India Healthcare 19.22 0.95 0.00 0.92
up Metropolis Healthcare Healthcare 43.16 1.76 0.00 0.88

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-Jul-2022

Fund Manager

— Jinesh Gopani since 30-Apr-2021

Education: Mr. Gopani is a B. Com (H) and MMS from Bharati Vidyapeeth Institute of Management Studies and Research.

Experience: Prior to joining Axis AMC he has worked with Birla Sun Life AMC, Voyager India Capital Pvt. Ltd., Emkay Shares & Stock Brokers Limited and Net worth Stock Broking Limited.

Interviews:

Funds Managed:


-0.35%

Change from previous, NAV as on 18-Aug-2022

Growth: ₹ 81.7964


Investment Strategy

The scheme seeks to provide returns before expenses that closely correspond to the total returns of the NIFTY Healthcare Index subject to tracking errors.

Investment Details

Min. Investment (₹) 5,000
Min. Addl Investment (₹) --
Min. SIP Investment (₹) --
Min. No of Cheques --
Min. Withdrawal (₹) --
Min. Balance (₹) --
Lock-in Period Not Applicable
Exit Load 0

Basic Details

Fund House: Axis Mutual Fund
Launch Date: 17-May-2021
Return Since Launch: -1.74%
Benchmark: NIFTY Healthcare TRI.
Riskometer: Very High
Type: Open-ended
Assets: ₹ 21 Cr (As on 31-Jul-2022)
Expense Ratio: 0.22% (As on 31-Jul-2022)
Risk Grade: --
Return Grade: --
Turnover: --

Contact Information

AMC: Axis Asset Management Company Ltd.

Address: "Axis House" - 1st Floor, C-2 - Wadia International Centre, Pandurang Budhkar Marg , Worli, Mumbai - 400025

Phone: 022-24255161

Fax: 022-43255199

Website: http://www.axismf.com

Registrar & Transfer Agent: KFin Technologies Ltd.

Address: 303, Vamsee Estates, Opp. Big Bazaar, Ameerpet, Hyderabad - 500016

Phone: 040-44857874

Email: [email protected]

Website: www.karvymfs.com

Upcoming Video

Investors' Hangout

Most-asked mutual fund queries answered

DateFri, 19-Aug-2022
Time12:30 PM - 12:40 PM

attending You have reserved a spot